Inside Lower Eyelid in CC
Inside Lower Eyelid in CC section, includes general infrmation about Inside Lower Eyelid Procedure, Inside Lower Eyelid CC Local News, Inside Lower Eyelid CC Surgeon Locator and other Inside Lower Eyelid related material.
Inside Lower Eyelid Procedure
Surgical rejuvenation of the eyelids or Blepharoplasty is a procedure usually performed on otherwise healthy patients who may have excess skin, muscle, and fat around the eyelids. The operation is done to rejuvenate the eyelids and achieves a more youthful appearance.
This approach is used only in the lower eyelid in select patients. Many of these patients may not need skin removed, but only excess fatty tissue. The tissues are separated to obtain access to the fat pockets in the lower eyelid.
The pockets of fat are exposed and a series of surgical instruments are used to remove the fat. The wound is allowed to heal. Sutures may be placed in the wound depending on the surgeon's preference. In select patients it is possible to have extra skin removed with another incision on the outside of the eyelid. Healing time may be up to two weeks.
There may be significant swelling and bruising following the procedure. Sometimes it may take longer to achieve the final results.
Other Inside Lower Eyelid Procedures
All Face Procedures
Inside Lower Eyelid CC (current)
Inside Lower Eyelid CC BOTOX® Cosmetic
Inside Lower Eyelid CC Ear Surgery
Inside Lower Eyelid CC Facelift
Inside Lower Eyelid CC Browlift
More CC info...
Caicos Islands Get out This article is an outline and needs more content. It has a template, but there is not enough information present. Please plunge forward and help it grow!
Caicos Islands Regions
Providenciales
North Caicos
Middle Caicos
East Caicos
South Caicos
West Caicos
Plastic Surgery News...
- Protein Associated with Poor Breast Cancer PrognosisHigh levels of the Ki-67 protein are associated with poor prognosis in early breast cancer patients, but it may not able to predict which patients will benefit from additional chemotherapy.The percentage of proliferating cells in a tumor is a predictor of breast cancer prognosis.
- ARM 52 seeks views on the reclassification of Voltarol Pain-Eze Emulgel from Pharmacy (P) to General Sales List (GSL); feedback is welcomed up until 8th April 2008. A consultation document discusses the rationale for reclassification, and notes that the company is requesting that the maximum pack size permitted for GSL supply be increased from 30g (current maximum) to 50g. Please see the link above for further details.